Skip to main content
. 2020 Jun 9;9(6):1797. doi: 10.3390/jcm9061797

Table 1.

Demographic and Baseline Characteristics of the participants.

Demographic Participants No. (%)
Child sex
Experimental group
Female 9 (64.3)
Male 5 (35.7)
Control group
Female 9 (64.3)
Male 5 (35.7)
Parental sex
Experimental group
Female 11 (78.6)
Male 3 (21.4)
Control group
Female 11 (78.6)
Male 3 (21.4)
Parental history of chronic Pain
Experimental group
Yes 5 (35.7)
No 9 (64.3)
Control group
Yes 4 (28.6)
No 10 (71.7)
Race child
Experimental group
Caucasian 13 (92.9)
Non-Caucasian 1 (7.1)
Control group
Caucasian 13 (92.9)
Non-Caucasian 1 (7.1)
Parental educational level
Experimental group
Low (≤high school
level education)
5 (35.7)
Middle (Bachelor’s
degree or equivalent)
6 (42.9)
High (≥Master’s
degree)
3 (21.4)
Control group
Low (≤high school
level education)
5 (35.7)
Middle (Bachelor’s
degree or equivalent)
5 (35.7)
High (≥Master’s
degree)
4 (28.6)
Demographic Mean (SD) Median (IQR) (Range)
Child age, years
Experimental group 9.21 (1.53) 9.00 (3.00) (7.00–12.00)
Control group 8.71 (1.73) 9.00 (3.25) (6.00–11.00)
Parental age, years
Experimental group 39.57 (4.18) 39.00 (5.25) (35.00–49.00)
Control group 37.57 (4.65) 38.00 (7.75) (29.00–44.00)
Pain duration, months
Experimental group 19.71 (12.68) 17.00 (15.75) (4.00–48.00)
Control group 28.36 (21.40) 24.00 (39.25) (3.00–70.00)
Pain episodes, n/month
Experimental group 21.29 (8.73) 23.50 (14.25) (3.00–31.00)
Control group 20.64 (14.73) 16.50 (17.75) (3.00–60.00)
Baseline Mean (SD) Median (IQR) [Range]
FDI-P score
Experimental group 11.00 (11.60) 6.50 (16.25) (0.00–43.00)
Control group 9.21 (8.54) 7.00 (6.25) (2.00–34.00)
FPS-R score
Experimental group 3.71 (2.20) 4.00 (2.50) (0.00–8.00)
Control group 5.14 (2.80) 5.00 (4.50) (0.00–10.00)
FOPQ-P score
Experimental group 41.50 (14.85) 37.50 (23.75) (24.00–73.00)
Control group 31.71 (9.23) 34 (14.25) (12.00–42.00)
PCS-P score
Experimental group 19.79 (9.54) 19.00 (12.25) (3.00–41.00)
Control group 22.29 (10.25) 23.50 (9.50) (2.00–40.00)
PPT Trapezius, kg/cm²
Experimental group 1.41 (0.85) 1.17 (0.61) (0.73–4.00)
Control group 1.15 (0.43) 1.02 (0.70) (0.68–2.05)
PPT Umbilicus, kg/cm²
Experimental group 1.04 (0.52) 1.05 (0.77) (0.13–2.10)
Control group 0.95 (0.32) 0.84 (0.36) (0.50–1.61)
PPT Tibia, kg/cm²
Experimental group 2.61 (1.12) 2.59 (1.44) (1.19–5.00)
Control group 2.47 (1.05) 2.36 (1.39) (1.08–4.50)
CPM, absolute difference
Experimental group −0.01 (0.59) −0.07 (0.51) (−0.63–1.76)
Control group −0.28 (0.37) −0.19 (1.10) (−1.08–0.30)
CPM, % change
Experimental group −7.90 (26.45) −6.75 (40.17) (−50.00–44.12)
Control group −32.64 (39.88) −22.54 (73.06) (−105.19–24.49)

Abbreviations: IQR: Interquartile range; SD: Standard deviation; PCS-P: Pain Catastrophizing Scale for Parents (score: 0–52); FDI-P: Functional Disability Inventory-Parent proxy (score: 0–60); FOPQ-P: Fear of Pain Questionnaire-Parent version (score: 0–92); FPS-R: Faces Pain Scale-Revised (range 0–10); PPT: Pain Pressure Threshold; CPM: Conditioned Pain Modulation; CPT: Cold Pressor Task; Calculations: CPM absolute difference = (PPT Trapezius–PPT Trapezius during CPM); CPM Percentage change = (((PPT Trapezius-PPT Trapezius during CPM)/PPT Trapezius during CPM)*100).